CD163 was suggested to be significantly correlated with gastric cancer differentiation, invasion depth, lymph node metastasis, and TNM stage (P < .05); while CD16 was not significantly correlated with each clinicopathological factor of gastric cancer (P > .05). This evidence concerns the gene CD163 and metastasis.